Reports Claim An Increase In Cancer Deaths Among Women By 2030

Image Source: france24.com
Image Source: france24.com

Breast cancer diagnoses are expected to rise by 60 percent by 2030, according to new reports. The American Cancer Society and Lancet says that many women, particularly those who live in poorer countries, are at increased risk of developing breast cancer. It is estimated that there will be around 5.5 million women diagnosed with the disease in the next decade and a half. This figure approximates the population of Denmark. These projections were announced during the most recent World Cancer Congress in Paris.

Both studies say that most deaths occur among young and middle-aged women. Most worrisome, the authors say, is that these forms of cancer are largely preventable and treatable through early detection. Cancer is considered the second leading cause of death after cardiovascular disease among women. However, in poorer countries, many adults do not have access to sufficient health care. Many women see an oncologist only when their situation is already severe.

Image Source: theguardian.co.uk
Image Source: theguardian.co.uk

These findings emphasize current medical theories that rapid economic transitions – which have brought about a change in physical activity, diet, and reproductive habits – have caused an increased risk for illnesses normally common in high-income countries. Unfortunately, while developing countries have adopted poorer health habits, healthcare has remained static. Countries with the highest death rates were Kenya, Mongolia, Papua New Guinea, Zimbabwe, and Malawi.

Authors of the study say that these are estimations. The number can be dramatically reduced with proper education and healthcare. Most importantly, treatment options are more effective on cases diagnosed early.

Sandra Balan is a staunch supporter of the American Cancer Society. To learn more about new findings on cancer, follow this blog.

Is There Finally a Cure For Breast Cancer?

The medical community was astounded by the recent news that an Indian teenager found a breast cancer cure. Krtin Nithiyandam, who lives in Epsom Surrey, claims that he has found a way to treat triple-negative breast cancer, a specific form of the disease that does not respond to most treatment methods.

Typical breast cancer treatments revolve around hormone therapy, as the condition is often caused by fluctuations of estrogen, progesterone, or certain growth chemicals. Treatment plans involve patients taking drugs that block excessive production of these hormones. These drugs are normally quite effective. However, triple-negative breast cancer – which affects around 7,500 women each year – is a special case. Doctors speculate that several factors cause the condition, thus, changing treatment. Those who are diagnosed with this illness usually have a combination of surgery, radiation, and chemotherapy; and even then, complete eradication of the disease is not certain.

Image Source: medicinenet.com
Image Source: medicinenet.com

Nithiyandam, who won the Google Science Fair in 2015 for developing a test that spots Alzheimer’s 10 years before it surfaces, says that he has found a way to change triple negative breast cancer cells so that they respond positively to treatment. The cells, which medical professionals call undifferentiated, do not have receptors which traditional cancer drugs latch on to. Nithiyandam says that blocking a specific protein in the cell could potentially build receptors.

Image Source: rd.com
Image Source: rd.com

Nithiyandam’s findings are currently being reviewed and tested by different medical groups. If proven, it could significantly improve the prognosis of the thousands of women battling breast cancer.

Sandra Balan is a passionate supporter of the American Cancer Society. She is constantly on the lookout for the latest cancer treatment news. You can learn more by liking this Facebook page.

New Study Shows Malaria Drug Can Be Used To Treat Cancer

Image Source: indiatimes.com
Image Source: indiatimes.com

A new study published in Nature Communications claims that an old malaria treatment drug can be used to reduce cancerous tumors. The drug, called atovaquone, was tested on mice which had tumors with low oxygen levels.

Scientists have found that cancer cells repair themselves faster in low oxygen environments. This is why radiotherapy is often considered hazardous, since cancer cells have the potential to grow faster after therapy. Tumors with low oxygen levels are typically more challenging to treat and usually metastasize to other areas.

However, it was found that atovaquone helps oxygenate the tumors so that they are more thoroughly destroyed during radiotherapy sessions. The malaria drug was tested on different sets of tumors and was seen to be effective for different types of cancers such as lung, head, neck, and brain cancer. Since this is an older medicine – and one used for a different illness altogether – it is readily available over the counter and from generic medicine manufacturers.

Image Source: pharmatimes.com
Image Source: pharmatimes.com

Authors of the study caution the public that results are from research in the initial stages and the medicine should not be considered a comprehensive treatment for cancer. Further research is necessary before oncologists will use atovaquone as a supplement for radiotherapy sessions. Yet this is an exciting discovery that opens doors to “new” treatments for cancer from other illness drugs.

Scientists and health professionals still do not understand the exact mechanics of the genesis of different forms of cancer, so cancer treatment has been in a protracted state of research. By testing other drugs and treatment, oncologists hope to reverse-deduce how cancer develops and thus effectively treat and/or prevent it.

Sandra Balan is a strong supporter of the American Cancer Society and actively looks for the latest news on cancer treatments. To learn more about developments in research, follow this Twitter account.

New Us Government Study Tackles Old Cellphone-Cancer Controversy

When mobile technology first became popular, there were many studies that claimed that increased cellular use could lead to cancer. This was a highly controversial statement – with many individuals cancelling their mobile subscriptions until empirical data suggested otherwise.

o-TALKING-CELL-PHONE-facebook
Image Source: huffingtonpost.com

Several more studies were undertaken. Most of these concluded that the amount of cellular exposure to develop cancer was almost impossible to attain; that is, the individual should be constantly and continually be on the phone for almost the entire day for several months. As far as mobile companies were concerned, the issue was over.

Recently, however, a major US government study reopened the topic, claiming the excessive cellphone exposure does indeed lead to cancer, at least among rats. Researchers of the study concluded that continuous exposure to radiofrequency radiation increases the potential of developing certain forms of cancer, particularly in the brain.

The upside is that the risk is relatively small, and the exact translation of the phenomenon to humans is still undetermined. Still, medical researchers are cautioning the public to be more vigilant with their cellphone usage. They argue that their findings do suggest that there is a correlation (and perhaps an undetermined causation) between mobile use and developing cancer.

web-mobile-phones-rex
Image Source: independent.co.uk

Further research still needs to be made, but this recent finding has caused a major ripple among cellular companies. People are once again questioning the health and safety hazards of using their cellphones.

Sandra Balan is a staunch supporter of the American Cancer Society and an advocate for education in the prevention and treatment of cancer. Learn more by viewing this LinkedIn profile.